all report title image

CHRONIC DISEASE MANAGEMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Chronic Disease Management Market, By Disease Type (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease, and Others (Arthritis, etc.)), By Service Type (Disease Management Programs, Remote Patient Monitoring, Telehealth Services, and Others (Diagnostic Services, etc.)), By Delivery Mode (On-premise, Web-based, and Cloud-based), By End User (Hospitals, Specialty Clinics, Home Care Settings, and Others (Pharmaceutical Companies, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Sep 2024
  • Code : CMI7375
  • Pages :165
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Key Developments

  • In June 2024, HealthSnap and Mount Sinai Medical Center launched a remote patient monitoring (RPM) and chronic care management (CCM) partnership as of March 2024. Currently active at three Mount Sinai locations, the program is set to expand to 13 locations across South Florida, aiming to serve up to 10,000 patients. The CCM program is expected to go live in July, initially supporting over 4,000 patients, with plans to scale up to 10,000 patients with chronic conditions in the future.
  • In January 2024, Amazon launched a new program aimed at connecting consumers with chronic condition management services as part of its ongoing healthcare initiatives. The program highlights eligible benefits for managing conditions like weight, diabetes, and other cardiometabolic issues when users search for related devices, such as glucose monitors, on Amazon. This initiative marks Amazon's latest step into the healthcare space, with Omada securing the first partnership in this program.
  • In November 2022, MedStar Health and Zephyr AI, Inc., a precision medicine startup, announced a partnership to enhance outcomes for chronic diseases, starting with type 2 diabetes (T2D). Zephyr AI's predictive analytics tool, Insights, will leverage MedStar Health's de-identified T2D data to accelerate therapy timing and reduce complications like renal failure and amputations.
  • In July 2021, The Union Health Ministry implemented three disease elimination programs under the National Vector Borne Diseases Control Programme (NVBDCP), targeting Malaria, Filaria, and Kala-Azar. These diseases are under elimination programs, not eradication. Government runs the National Leprosy Eradication Programme (NLEP) and the National TB Elimination Programme (NTEP).

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.